CRL
Price
$178.05
Change
+$7.61 (+4.46%)
Updated
Nov 25 closing price
Capitalization
8.76B
84 days until earnings call
Intraday BUY SELL Signals
TMO
Price
$597.78
Change
+$11.71 (+2.00%)
Updated
Nov 25 closing price
Capitalization
224.59B
70 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CRL vs TMO

Header iconCRL vs TMO Comparison
Open Charts CRL vs TMOBanner chart's image
Charles River Laboratories International
Price$178.05
Change+$7.61 (+4.46%)
Volume$789.48K
Capitalization8.76B
Thermo Fisher Scientific
Price$597.78
Change+$11.71 (+2.00%)
Volume$1.8M
Capitalization224.59B
CRL vs TMO Comparison Chart in %
CRL
Daily Signal:
Gain/Loss:
TMO
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CRL vs. TMO commentary
Nov 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRL is a StrongBuy and TMO is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 26, 2025
Stock price -- (CRL: $178.05 vs. TMO: $597.78)
Brand notoriety: CRL and TMO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CRL: 69% vs. TMO: 83%
Market capitalization -- CRL: $8.76B vs. TMO: $224.59B
CRL [@Medical Specialties] is valued at $8.76B. TMO’s [@Medical Specialties] market capitalization is $224.59B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $12.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRL’s FA Score shows that 1 FA rating(s) are green whileTMO’s FA Score has 2 green FA rating(s).

  • CRL’s FA Score: 1 green, 4 red.
  • TMO’s FA Score: 2 green, 3 red.
According to our system of comparison, TMO is a better buy in the long-term than CRL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRL’s TA Score shows that 4 TA indicator(s) are bullish while TMO’s TA Score has 3 bullish TA indicator(s).

  • CRL’s TA Score: 4 bullish, 6 bearish.
  • TMO’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, TMO is a better buy in the short-term than CRL.

Price Growth

CRL (@Medical Specialties) experienced а +9.55% price change this week, while TMO (@Medical Specialties) price change was +3.78% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +5.45%. For the same industry, the average monthly price growth was -0.06%, and the average quarterly price growth was +32.28%.

Reported Earning Dates

CRL is expected to report earnings on Feb 18, 2026.

TMO is expected to report earnings on Feb 04, 2026.

Industries' Descriptions

@Medical Specialties (+5.45% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TMO($225B) has a higher market cap than CRL($8.76B). CRL has higher P/E ratio than TMO: CRL (577.05) vs TMO (34.53). TMO YTD gains are higher at: 15.227 vs. CRL (-3.548). TMO has higher annual earnings (EBITDA): 11.3B vs. CRL (528M). TMO has more cash in the bank: 3.55B vs. CRL (183M). CRL has less debt than TMO: CRL (2.79B) vs TMO (35.7B). TMO has higher revenues than CRL: TMO (43.7B) vs CRL (4.03B).
CRLTMOCRL / TMO
Capitalization8.76B225B4%
EBITDA528M11.3B5%
Gain YTD-3.54815.227-23%
P/E Ratio577.0534.531,671%
Revenue4.03B43.7B9%
Total Cash183M3.55B5%
Total Debt2.79B35.7B8%
FUNDAMENTALS RATINGS
CRL vs TMO: Fundamental Ratings
CRL
TMO
OUTLOOK RATING
1..100
6274
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
70
Overvalued
PROFIT vs RISK RATING
1..100
10067
SMR RATING
1..100
8758
PRICE GROWTH RATING
1..100
5816
P/E GROWTH RATING
1..100
133
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TMO's Valuation (70) in the Medical Specialties industry is in the same range as CRL (91) in the Miscellaneous Commercial Services industry. This means that TMO’s stock grew similarly to CRL’s over the last 12 months.

TMO's Profit vs Risk Rating (67) in the Medical Specialties industry is somewhat better than the same rating for CRL (100) in the Miscellaneous Commercial Services industry. This means that TMO’s stock grew somewhat faster than CRL’s over the last 12 months.

TMO's SMR Rating (58) in the Medical Specialties industry is in the same range as CRL (87) in the Miscellaneous Commercial Services industry. This means that TMO’s stock grew similarly to CRL’s over the last 12 months.

TMO's Price Growth Rating (16) in the Medical Specialties industry is somewhat better than the same rating for CRL (58) in the Miscellaneous Commercial Services industry. This means that TMO’s stock grew somewhat faster than CRL’s over the last 12 months.

CRL's P/E Growth Rating (1) in the Miscellaneous Commercial Services industry is in the same range as TMO (33) in the Medical Specialties industry. This means that CRL’s stock grew similarly to TMO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRLTMO
RSI
ODDS (%)
Bearish Trend 1 day ago
69%
Bearish Trend 1 day ago
50%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
55%
Momentum
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 1 day ago
62%
MACD
ODDS (%)
Bullish Trend 1 day ago
69%
Bearish Trend 1 day ago
57%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
62%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
73%
Bullish Trend 1 day ago
61%
Advances
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 15 days ago
60%
Declines
ODDS (%)
Bearish Trend 8 days ago
69%
Bearish Trend 7 days ago
63%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 1 day ago
56%
Aroon
ODDS (%)
Bearish Trend 1 day ago
75%
Bullish Trend 1 day ago
63%
View a ticker or compare two or three
Interact to see
Advertisement
CRL
Daily Signal:
Gain/Loss:
TMO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
FOREX / NAMEPrice $Chg $Chg %
HKDCNY0.91N/A
N/A
Hong Kong Dollar - China Yuan
RUBEUR0.01N/A
N/A
Russia Ruble - Euro
BAGAX13.75N/A
N/A
Brown Advisory Growth Equity Adv
OSTFX20.70N/A
N/A
Osterweis
ACVDX11.07N/A
N/A
American Century International Val R6

CRL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRL has been loosely correlated with A. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if CRL jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRL
1D Price
Change %
CRL100%
+4.46%
A - CRL
65%
Loosely correlated
+2.34%
RVTY - CRL
64%
Loosely correlated
+4.96%
MTD - CRL
63%
Loosely correlated
+2.44%
TMO - CRL
60%
Loosely correlated
+2.00%
NOTV - CRL
58%
Loosely correlated
+3.91%
More